Alternatives to the digitalis glycosides for heart failure.
作者信息
Johnston G D
出版信息
Br Med J (Clin Res Ed). 1985 Mar 16;290(6471):803-4. doi: 10.1136/bmj.290.6471.803.
Abstract
摘要
相似文献
1
Alternatives to the digitalis glycosides for heart failure.
Br Med J (Clin Res Ed). 1985 Mar 16;290(6471):803-4. doi: 10.1136/bmj.290.6471.803.
2
Inotropic drugs for treatment of the failing heart.
Cardiovasc Clin. 1984;14(3):1-17.
3
New positive inotropic agents for congestive heart failure.
N Engl J Med. 1986 Aug 7;315(6):396-7. doi: 10.1056/NEJM198608073150614.
4
Congestive heart failure.
Med Clin North Am. 1986 Jul;70(4):829-51. doi: 10.1016/s0025-7125(16)30927-0.
5
Inotropic drugs in the treatment of heart failure.
Hosp Pract (Off Ed). 1984 May;19(5):57-67, 70-1. doi: 10.1080/21548331.1984.11702817.
6
[Rational and irrational approach to the inotropic agent therapy of heart failure].
Clin Ter. 1988 Sep 30;126(6):421-6.
7
Some new positive inotropic agents.
Acta Med Scand Suppl. 1986;707:65-73.
8
Milrinone, a new agent for the treatment of congestive heart failure.
Clin Pharm. 1986 Mar;5(3):201-5.
9
Effects of amrinone on myocardial energetics in severe congestive heart failure.
Am J Cardiol. 1985 Jul 22;56(3):16B-18B. doi: 10.1016/0002-9149(85)91190-7.
10
[New drugs with positive inotropic action].
Kardiol Pol. 1982;25(4):357-65.
引用本文的文献
1
Digitalis: where are we now?
Br Heart J. 1985 Sep;54(3):227-33. doi: 10.1136/hrt.54.3.227.
2
The search of an ideal oral positive inotropic agent.
Eur J Clin Pharmacol. 1986;30(5):509-12. doi: 10.1007/BF00542407.
3
Digoxin after myocardial infarction. Does it have a role?
Drugs. 1989 May;37(5):577-82. doi: 10.2165/00003495-198937050-00001.
本文引用的文献
1
Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
Am J Cardiol. 1981 Mar;47(3):665-9. doi: 10.1016/0002-9149(81)90552-x.
2
Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
Circulation. 1981 Jan;63(1):96-101. doi: 10.1161/01.cir.63.1.96.
3
Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Circulation. 1980 Jul;62(1):28-34. doi: 10.1161/01.cir.62.1.28.
4
Clinical results with prenalterol in patients with heart failure.
Am Heart J. 1981 Sep;102(3 Pt 2):548-54. doi: 10.1016/0002-8703(81)90743-2.
5
Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
N Engl J Med. 1983 Sep 29;309(13):748-56. doi: 10.1056/NEJM198309293091302.
6
Side effects of amrinone therapy.
Br Heart J. 1983 May;49(5):447-51. doi: 10.1136/hrt.49.5.447.
7
Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
Circulation. 1983 May;67(5):1065-70. doi: 10.1161/01.cir.67.5.1065.
8
Regression of atherosclerosis in humans: fact or myth?
Circulation. 1981 Jul;64(1):1-3. doi: 10.1161/01.cir.64.1.1.
9
Beneficial hemodynamic effects of oral levodopa in heart failure. Relation to the generation of dopamine.
N Engl J Med. 1984 May 24;310(21):1357-62. doi: 10.1056/NEJM198405243102105.
10
Digoxin withdrawal after cardiac failure in patients with sinus rhythm.
J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):229-34. doi: 10.1097/00005344-198303000-00011.
Zotero 插件